Moreover, anti-C1q antibodies showed a stronger association with renal disease activity in SLE patients than anti-dsDNA antibodies and reduction of C3 and C4 in terms of diagnostic specificity. This evidence concerns the gene C3 and systemic lupus erythematosus.